Atreca, Inc. to Present Cancer Immunotherapy Platform and Data at the PepTalk 2017 Conference – Business Wire (press release)
|
Atreca, Inc. to Present Cancer Immunotherapy Platform and Data at the PepTalk 2017 Conference
Business Wire (press release) REDWOOD CITY, Calif.–(BUSINESS WIRE)–Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today the scheduled presentation of positive … |
